E-Qure Corp. announced that it signed a distribution agreement with Tech - Médica Equipos Médicos S.A.S. in Colombia for the company's patented Bio-electrical Signal Therapy device, a breakthrough novel electrotherapy for the non-invasive treatment of hard-to-heal chronic wounds. This distribution agreement in Colombia is part of E-QURE's worldwide launch of its BST Device, serving the $25 billion global wound care market. E-QURE previously singed distribution agreements in Argentina and Israel, where marketing clearance is expected soon. E-QURE granted TeckMedica the exclusive rights to distribute its BST device and accompanying disposable electrodes for the treatment of chronic wounds. The 5-year agreement includes increasing minimum annual sales quotas. TeckMedica will make an initial advance payment to E-QURE which will be applied against the first year's quota, in addition to placing an initial agreed minimum order upon receiving local marketing approval in Colombia. E-QURE will provide TeckMedica with supplies of the BST Device and disposable electrodes for treatment of patients in hospitals, long-term care facilities, medical centers and out-patient clinics. TeckMedica is responsible for securing any product certification, permit, license or approval that may be required for marketing, sales, sublicensing and treatment in Colombia.